Centre Chirurgical Marie Lannelongue   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Plessis-Robinson France (1977)

Organization Overview

First Clinical Trial
2010
NCT01141127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Chirurgical Marie Lannelongue

Active Ingredients

Drugs in Phase 3 Trials (2)

dexamethasone (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Phase 2 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Hemorrhage (Phase 2)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3